Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Hoffmann, K; Franz, C; Xiao, Z; Mohr, E; Serba, S; Büchler, MW; Schemmer, P.
Sorafenib modulates the gene expression of multi-drug resistance mediating ATP-binding cassette proteins in experimental hepatocellular carcinoma.
Anticancer Res. 2010; 30(11):4503-4508
Web of Science
PubMed
- Leading authors Med Uni Graz
- Schemmer Peter
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Abstract:
- High ATP-binding cassette (ABC) protein expression leads to intrinsic drug resistance of hepatocellular carcinoma (HCC). The aim of this study was to investigate the potential chemosensitizing effects of sorafenib on the multi-drug resistance (MDR) phenotype. The ABC-protein gene expression and the cellular survival were determined by RT-PCR analysis and MTT assay in HUH7 cells. Sorafenib inhibits MDR. The ABC-protein mRNA expression decreased by up to 51% (p ≤ 0.01). Addition of sorafenib to conventional chemotherapy restored the chemosensitivity. Combination of gemcitabine plus sorafenib decreased the ABC-protein mRNA levels by up to 77%, compared to gemcitabine monotherapy (p ≤ 0.001). Doxorubicin plus sorafenib decreased the ABC-protein mRNA levels up to 74% compared to doxorubicin monotherapy (p ≤ 0.001). This study provides evidence that the MDR phenotype of HCC cells can be modulated by the multi-kinase inhibitor sorafenib and consequentially may lead towards personalized therapies in patients with highly resistant tumors.
- Find related publications in this database (using NLM MeSH Indexing)
- Antineoplastic Combined Chemotherapy Protocols - pharmacology
- Benzenesulfonates - administration & dosage
- Carcinoma, Hepatocellular - drug therapy
- Carcinoma, Hepatocellular - genetics
- Carcinoma, Hepatocellular - pathology
- Cell Proliferation - drug effects
- Deoxycytidine - administration & dosage
- Deoxycytidine - analogs & derivatives
- Doxorubicin - administration & dosage
- Drug Resistance, Multiple - drug effects
- Drug Resistance, Neoplasm - drug effects
- Gene Expression Regulation, Neoplastic - drug effects
- Humans -
- Liver Neoplasms - drug therapy
- Liver Neoplasms - genetics
- Liver Neoplasms - pathology
- Multidrug Resistance-Associated Proteins - genetics
- Multidrug Resistance-Associated Proteins - metabolism
- Niacinamide - analogs & derivatives
- Phenylurea Compounds -
- Pyridines - administration & dosage
- RNA, Messenger - genetics
- Reverse Transcriptase Polymerase Chain Reaction -
- Survival Rate -
- Tumor Cells, Cultured -
- Find related publications in this database (Keywords)
- Tyrosine kinase pathway
- P-glycoprotein
- chemosensitivity sorafenib
- multidrug resistance
- hepatocellular carcinoma cells